MARKET

BSX

BSX

Boston Scien Cp
NYSE
67.13
+0.92
+1.39%
After Hours: 67.50 +0.37 +0.55% 19:25 03/01 EST
OPEN
66.35
PREV CLOSE
66.21
HIGH
67.40
LOW
66.30
VOLUME
5.66M
TURNOVER
0
52 WEEK HIGH
67.40
52 WEEK LOW
46.20
MARKET CAP
98.49B
P/E (TTM)
62.57
1D
5D
1M
3M
1Y
5Y
Why Is Boston Scientific (BSX) Up 2.1% Since Last Earnings Report?
NASDAQ · 1d ago
Boston Sci gets FDA approval for Agent in-stent restenosis balloon
Seeking Alpha · 1d ago
Boston Scientific: FDA Approves AGENT Drug-Coated Balloon - Quick Facts
NASDAQ · 1d ago
Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon
First coronary drug-coated balloon in U.S. Provides safe, effective alternative to treat coronary in-stent restenosis and reduce risk of reoccurrence. Boston Scientific has received FDA approval for the AGENT™ Drug-Coated Balloon. The balloon is indicated to treat patients with coronary artery disease. The AGENT DCB is an alternative to traditional balloon angioplasty.
PR Newswire · 1d ago
C3.ai's (AI) Stock Is Soaring After Earnings But is it Time to Buy?
NASDAQ · 2d ago
Boston Scientific (BSX) Receives a Buy from Wells Fargo
TipRanks · 2d ago
We Ran A Stock Scan For Earnings Growth And Boston Scientific (NYSE:BSX) Passed With Ease
Boston Scientific's earnings per share have been soaring, with growth rates of 41% in the last 3 years. The company has a large insider ownership stake in the company worth US$200m. Boston Scientific is one of a handful of companies in the US with promising growth potential. The firm has grown its revenue by 12% to US$14b over the past year.
Simply Wall St · 2d ago
Boston Scientific Announces Completion of €2.0 Billion Offering of Senior Notes
Boston Scientific Corporation completed a public offering of €750,000,000 notes due 2029 and 2032. The Company intends to use the net proceeds to finance the purchase price of Axonics, Inc. Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world.
PR Newswire · 4d ago
More
About BSX
Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy and Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions. Its Urology and Neuromodulation business develops and manufactures devices to treat various urological, neurological movement disorders and pelvic conditions. Its Cardiac Rhythm Management develops and manufactures a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment include Interventional Cardiology and Peripheral Interventions. Its Interventional Cardiology develops and manufactures technologies for diagnosing and treating coronary artery disease and structural heart conditions. Its product offerings include 360 Clips and RESONATE, among others.

Webull offers Boston Scientific Corporation stock information, including NYSE: BSX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BSX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BSX stock methods without spending real money on the virtual paper trading platform.